Evidence map›Paper›PMID 23001988›Full record

ReviewCold Spring Harbor perspectives in biology2012

Targeting Wnt pathways in disease.

Zachary F Zimmerman, Randall T Moon, Andy J Chien

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Decreased Serum Dickkopf-1 Levels After Hypoglycemic Therapy in Patients with Type 2 Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Wnt-C59 inhibits proinflammatory cytokine expression by reducing the interaction between β-catenin and NF-κB in LPS-stimulated epithelial and macrophage cells.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Article
  19. The Journal of clinical and aesthetic dermatology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zachary F ZimmermanDepartment of Medicine, Division of Oncology, University of Washington, Seattle, 98195, USA.
Randall T Moon
Andy J Chien
University of Washington · USHoward Hughes Medical Institute · US

Funding

TRAINING IN CANCER BIOLOGY &TRANSPLANTATIONT32CA009515 · NCI · UNIVERSITY OF WASHINGTON · PI NANCY ELLEN DAVIDSON, Effie W Petersdorf · 1985 to 2026
$16.2M
Investigation of the Wnt/PCP pathway in human malignant melanomaK08CA128565 · NCI · UNIVERSITY OF WASHINGTON · PI CHIEN, ANDY J · 2007 to 2010
$626k
Howard Hughes Medical InstituteNCI NIH HHS K08 CA128565NCI NIH HHS T32 CA009515NCI NIH HHS T32 CA009515-2
6 · The paper itself

Abstract

Wnt-mediated signal transduction pathways have long been recognized for their roles in regulating embryonic development, and have more recently been linked to cancer, neurologic diseases, inflammatory diseases, and disorders of endocrine function and bone metabolism in adults. Although therapies targeting Wnt signaling are attractive in theory, in practice it has been difficult to obtain specific therapeutics because many components of Wnt signaling pathways are also involved in other cellular processes, thereby reducing the specificity of candidate therapeutics. New technologies, and advances in understanding the mechanisms of Wnt signaling, have improved our understanding of the nuances of Wnt signaling and are leading to promising new strategies to target Wnt signaling pathways.

Indexed as

Adenomatous Polyposis Coli ProteinAnti-Inflammatory Agents, Non-Steroidalbeta CateninDrug Delivery SystemsDrug DiscoveryDrug TherapyHumansNeoplasmsReceptors, Cytoplasmic and NuclearWnt Signaling PathwayAdenomatous Polyposis Coli ProteinAnti-Inflammatory Agents, Non-SteroidalAPC protein, humanbeta CateninReceptors, Cytoplasmic and Nuclear

Identifiers

PMID23001988
PMCPMC3536347
OpenAlexW2129854864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.